leading brands of glp-1 agonists in biopharma Novo inks Ascendis deal to develop long-acting GLP-1, other metabolic drugs U.S. GLP-1 Receptor Agonist Market
Pay in 4 interest-free payments of $5.55 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12

























